Aggregated networks were constructed by combining gene expression data from multiple samples within each breast cancer subtype and healthy tissue, producing a collective overview of genomic interactions in five networks, one for each breast cancer subtype (Luminal A, Luminal B, Her2, Basal) and one for the normal tissue phenotype. This evidence concerns the gene ERBB2 and breast cancer.